Observational studyJournal of the American Heart Association2026
Evaluation of Pulmonary Artery Flow Reserve in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Pilot Study.
Observational study in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPressure-wire fractional flow reserve (FFR) can guide balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension, but lesion crossing with a distal wire increases cost and procedural risk. We developed an angiography-derived physiologic index-pulmonary artery flow reserve (PFR)-computed from selective pulmonary angiography using fluid-dynamic modeling without distal pressure-wire advancement.
methodsIn this prospective observational study, selective pulmonary angiography was acquired in 2 projections for type A (ring-like), type B (web lesion) and type C (subtotal) pulmonary artery lesions. Proximal pressure (Pa) was measured at the target vessel ostium using a pressure-sensor catheter; flow velocity was estimated by frame counting; pressure drop (ΔP) was computed by a proprietary computational fluid dynamics approach, and PFR was derived as (Pa - ΔP)/Pa. Pressure-wire FFR (Pd/Pa) served as the reference standard (FFR ≤0.80). Diagnostic performance was assessed by receiver operating characteristic analysis and agreement by Bland-Altman analysis.
resultsFifty-two vessels in 29 patients were analyzed. Mean FFR and PFR were 0.57 ± 0.23 and 0.58 ± 0.24; 44 vessels had FFR ≤0.80. PFR showed excellent discrimination for FFR ≤0.80 (area under the curve 0.981, 95% CI 0.935-1.000), with sensitivity 94.1% (95% CI 80.9%-98.7%) and specificity 87.5% (95% CI 64.0%-97.0%) at an optimal PFR cutoff of 0.77. Agreement was high (bias 0.0076; 95% limits of agreement -0.1037 to 0.1190), and correlation was strong (
conclusionsAngiography-derived PFR demonstrated strong agreement with pressure-wire FFR for physiologic assessment of pulmonary artery stenoses in chronic thromboembolic pulmonary hypertension and may provide a simpler alternative to distal pressure-wire measurements to support physiology-guided balloon pulmonary angioplasty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.